From Grief to Global Change: How the STARS Program Empowers Advocates to Drive Lung Cancer Research

… from a grieving family member into a passionate patient research advocate. Despite not having a background in healthcare or cancer research, Caleb was driven to make a difference. Together with … generating critical data that could shape future cancer research in Nigeria. Today, Caleb is part of the IASLC …

IASLC, LCRF Request Proposals for New Research Grant

… Research teams with integrated projects focused on curing … over 4 years. … IASLC, LCRF Request Proposals for New Research Grant … Erin Jungmeyer …

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

… The initiatives include a $2.5 million, 4-year research grant and projects to improve lung cancer biomarker … Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic …

Regulating Artificial Intelligence

… regulate the use of artificial intelligence in clinical research? How likely is it that AI could lead us to erroneous … data-driven tools. ILCN:  Another potential use for AI in research could be evaluating disease burden. To what extent do … Singh:  FDA recognizes the interest and potential for AI research tools to aid in disease evaluation, such as with …

Narrow Focus Allows Pragmatica-Lung Trial to Minimize Eligibility Criteria, Significantly Reduce Data Collection, Researcher Says

… Criteria, Significantly Reduce Data Collection, Researcher Says … Erin Jungmeyer …

Passing of The Baton—On the Death of Patient Research Advocates

… says. … Passing of The Baton—On the Death of Patient Research Advocates … Angus Pratt …

Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines

… Cultural Context Largely Absent in Advanced Care Planning Research, Guidelines …

Funding Opportunities for Innovative Multidisciplinary Cancer Research Teams

… Opportunities for Innovative Multidisciplinary Cancer Research Teams …

US FDA’s Review of Single-Country ‘Me Too’ Drugs: A Clinical Trialist Perspective

… of care and limited resources to review applications, researchers say they support the agency’s decision not to …

Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture

… program bringing together patient care, education, and research, and is co-chair of the Skin Toxicity Study Group of …

Pragmatic Approach to Trial Design Born from Lung-MAP Substudy

… new pragmatic approach to trial design can streamline research and ultimately benefit patients. … Pragmatic Approach …

Real-World Data from Taiwan Shows Stage Shift Has Improved Lung Cancer Survival Rates

… Researchers say increased screening of at-risk populations, …